| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adenoviruses, Human | 23 | 2019 | 28 | 3.230 |
Why?
|
| Adenovirus E1B Proteins | 16 | 2015 | 19 | 2.780 |
Why?
|
| Adenovirus E4 Proteins | 17 | 2019 | 17 | 2.710 |
Why?
|
| Virus Replication | 17 | 2019 | 42 | 2.700 |
Why?
|
| Adenoviridae | 14 | 2018 | 68 | 2.360 |
Why?
|
| DNA, Viral | 17 | 2015 | 55 | 1.810 |
Why?
|
| Adenoviridae Infections | 9 | 2015 | 14 | 1.810 |
Why?
|
| Host-Pathogen Interactions | 3 | 2019 | 24 | 0.900 |
Why?
|
| Adenovirus Infections, Human | 4 | 2019 | 6 | 0.790 |
Why?
|
| Virus Latency | 4 | 2016 | 7 | 0.740 |
Why?
|
| Hela Cells | 21 | 2016 | 72 | 0.720 |
Why?
|
| Cell Nucleus | 11 | 2019 | 111 | 0.610 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2015 | 42 | 0.580 |
Why?
|
| Cytoplasm | 6 | 2020 | 29 | 0.570 |
Why?
|
| Streptococcus pneumoniae | 2 | 2017 | 38 | 0.560 |
Why?
|
| Vesicular stomatitis Indiana virus | 4 | 2022 | 16 | 0.560 |
Why?
|
| Oncogene Proteins | 2 | 2014 | 6 | 0.550 |
Why?
|
| Lymphocytes | 6 | 2017 | 55 | 0.530 |
Why?
|
| RNA, Viral | 5 | 2022 | 49 | 0.510 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2016 | 24 | 0.480 |
Why?
|
| Chromosomes, Human, Pair 21 | 2 | 2008 | 8 | 0.480 |
Why?
|
| Leukemia | 1 | 2016 | 38 | 0.470 |
Why?
|
| Open Reading Frames | 5 | 2009 | 21 | 0.460 |
Why?
|
| Ear, Middle | 1 | 2015 | 7 | 0.450 |
Why?
|
| Otitis Media | 1 | 2015 | 24 | 0.450 |
Why?
|
| Apoptosis Inducing Factor | 2 | 2014 | 2 | 0.440 |
Why?
|
| Pneumococcal Infections | 1 | 2015 | 30 | 0.440 |
Why?
|
| Fetal Blood | 1 | 2015 | 34 | 0.440 |
Why?
|
| Cell Line | 15 | 2018 | 454 | 0.430 |
Why?
|
| Humans | 51 | 2022 | 32274 | 0.420 |
Why?
|
| Cell Cycle | 4 | 2003 | 75 | 0.390 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 2 | 2015 | 7 | 0.390 |
Why?
|
| Viral Proteins | 6 | 2022 | 30 | 0.360 |
Why?
|
| Lymphocyte Activation | 3 | 2020 | 94 | 0.350 |
Why?
|
| DNA Damage | 3 | 2006 | 90 | 0.340 |
Why?
|
| Gene Expression Regulation, Viral | 5 | 2012 | 11 | 0.330 |
Why?
|
| Mutation | 8 | 2009 | 497 | 0.330 |
Why?
|
| Animals | 18 | 2022 | 8199 | 0.310 |
Why?
|
| Histones | 2 | 2009 | 50 | 0.310 |
Why?
|
| Adenovirus E1A Proteins | 5 | 2019 | 10 | 0.300 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2009 | 3 | 0.300 |
Why?
|
| DNA Replication | 3 | 2009 | 33 | 0.300 |
Why?
|
| Nucleocapsid | 2 | 2020 | 3 | 0.290 |
Why?
|
| S Phase | 3 | 2003 | 15 | 0.270 |
Why?
|
| Cell Line, Tumor | 6 | 2018 | 729 | 0.240 |
Why?
|
| DNA-Binding Proteins | 6 | 2009 | 149 | 0.230 |
Why?
|
| Mice | 10 | 2022 | 2571 | 0.220 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2004 | 81 | 0.220 |
Why?
|
| Nuclear Proteins | 5 | 2006 | 74 | 0.220 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2020 | 99 | 0.220 |
Why?
|
| Postural Balance | 1 | 2016 | 142 | 0.210 |
Why?
|
| Pesticides | 1 | 2016 | 135 | 0.210 |
Why?
|
| Occupational Exposure | 1 | 2016 | 159 | 0.210 |
Why?
|
| Transients and Migrants | 1 | 2016 | 197 | 0.210 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 198 | 0.200 |
Why?
|
| Protein Structure, Secondary | 2 | 2002 | 59 | 0.190 |
Why?
|
| Tissue Scaffolds | 2 | 2019 | 431 | 0.190 |
Why?
|
| Ribonucleoproteins | 2 | 2022 | 15 | 0.190 |
Why?
|
| Klebsiella Infections | 1 | 2022 | 6 | 0.190 |
Why?
|
| Klebsiella pneumoniae | 1 | 2022 | 14 | 0.190 |
Why?
|
| HIV Seropositivity | 1 | 2022 | 14 | 0.180 |
Why?
|
| HIV-1 | 1 | 2022 | 46 | 0.180 |
Why?
|
| Phosphorylation | 5 | 2009 | 250 | 0.180 |
Why?
|
| Poly(ADP-ribose) Polymerases | 2 | 2014 | 11 | 0.170 |
Why?
|
| Hispanic Americans | 1 | 2016 | 772 | 0.170 |
Why?
|
| Genetic Variation | 1 | 2002 | 248 | 0.160 |
Why?
|
| Motion | 1 | 2020 | 12 | 0.160 |
Why?
|
| Interleukin-4 | 1 | 2020 | 22 | 0.160 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2020 | 31 | 0.160 |
Why?
|
| Chromatin | 1 | 2019 | 26 | 0.160 |
Why?
|
| alpha-Galactosidase | 1 | 2019 | 3 | 0.150 |
Why?
|
| Bone Substitutes | 1 | 2019 | 9 | 0.150 |
Why?
|
| Up-Regulation | 2 | 2018 | 193 | 0.150 |
Why?
|
| Genes, Viral | 4 | 2004 | 6 | 0.150 |
Why?
|
| Transplantation, Heterologous | 1 | 2019 | 109 | 0.150 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 109 | 0.150 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2009 | 64 | 0.140 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2018 | 12 | 0.140 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2018 | 38 | 0.140 |
Why?
|
| Tamoxifen | 1 | 2018 | 59 | 0.140 |
Why?
|
| Autophagy | 1 | 2018 | 55 | 0.140 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2018 | 83 | 0.140 |
Why?
|
| RNA, Messenger | 5 | 1999 | 499 | 0.140 |
Why?
|
| Molecular Sequence Data | 6 | 2004 | 359 | 0.130 |
Why?
|
| Adult | 4 | 2016 | 9256 | 0.130 |
Why?
|
| Glioma | 1 | 2018 | 137 | 0.130 |
Why?
|
| Oncolytic Virotherapy | 2 | 2018 | 16 | 0.120 |
Why?
|
| Virus Assembly | 1 | 2016 | 4 | 0.120 |
Why?
|
| HIV Infections | 1 | 2022 | 450 | 0.120 |
Why?
|
| Leukemia, B-Cell | 1 | 2016 | 5 | 0.120 |
Why?
|
| Microtubules | 1 | 2016 | 18 | 0.120 |
Why?
|
| G1 Phase | 3 | 2003 | 10 | 0.120 |
Why?
|
| Chromosome Mapping | 3 | 2008 | 188 | 0.120 |
Why?
|
| Cluster Analysis | 1 | 2016 | 120 | 0.120 |
Why?
|
| Protein Biosynthesis | 2 | 2005 | 42 | 0.120 |
Why?
|
| Organelles | 1 | 2015 | 4 | 0.120 |
Why?
|
| B-Lymphocytes | 1 | 2016 | 79 | 0.120 |
Why?
|
| Cytological Techniques | 1 | 2015 | 17 | 0.120 |
Why?
|
| Child | 4 | 2016 | 2434 | 0.110 |
Why?
|
| Translocation, Genetic | 1 | 2015 | 20 | 0.110 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2015 | 18 | 0.110 |
Why?
|
| DNA Repair | 2 | 2005 | 55 | 0.110 |
Why?
|
| Age Factors | 2 | 2016 | 1179 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 314 | 0.110 |
Why?
|
| Rabbits | 1 | 2015 | 219 | 0.110 |
Why?
|
| Molecular Weight | 3 | 2004 | 55 | 0.110 |
Why?
|
| Virion | 4 | 2016 | 7 | 0.110 |
Why?
|
| Oncogene Proteins, Viral | 2 | 1991 | 3 | 0.100 |
Why?
|
| DNA-Activated Protein Kinase | 3 | 2009 | 3 | 0.100 |
Why?
|
| Amino Acid Sequence | 5 | 2004 | 290 | 0.100 |
Why?
|
| Adenovirus E3 Proteins | 1 | 2013 | 1 | 0.100 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2008 | 12 | 0.100 |
Why?
|
| JC Virus | 1 | 2013 | 20 | 0.100 |
Why?
|
| Tumor Virus Infections | 1 | 2013 | 21 | 0.100 |
Why?
|
| Polyomavirus Infections | 1 | 2013 | 20 | 0.100 |
Why?
|
| Gene Expression | 3 | 2006 | 345 | 0.100 |
Why?
|
| Histone Acetyltransferases | 1 | 2012 | 5 | 0.100 |
Why?
|
| Infant, Newborn | 1 | 2015 | 666 | 0.100 |
Why?
|
| Transcription Factors | 4 | 2005 | 183 | 0.090 |
Why?
|
| Models, Biological | 3 | 2010 | 408 | 0.090 |
Why?
|
| Achilles Tendon | 1 | 2012 | 26 | 0.090 |
Why?
|
| Transfection | 2 | 2003 | 204 | 0.090 |
Why?
|
| Transplantation, Homologous | 1 | 2012 | 158 | 0.090 |
Why?
|
| Oncolytic Viruses | 1 | 2012 | 8 | 0.090 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2012 | 19 | 0.090 |
Why?
|
| Adolescent | 3 | 2015 | 3517 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2013 | 181 | 0.090 |
Why?
|
| Protein-Serine-Threonine Kinases | 2 | 2009 | 49 | 0.090 |
Why?
|
| Apolipoproteins | 1 | 2013 | 194 | 0.090 |
Why?
|
| Apoptosis | 2 | 2018 | 375 | 0.090 |
Why?
|
| Phosphoproteins | 2 | 2016 | 54 | 0.080 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 1083 | 0.080 |
Why?
|
| Signal Transduction | 3 | 2018 | 727 | 0.080 |
Why?
|
| Lipoproteins, HDL | 1 | 2013 | 250 | 0.080 |
Why?
|
| Virulence | 2 | 2022 | 20 | 0.080 |
Why?
|
| Arginine | 2 | 2002 | 23 | 0.080 |
Why?
|
| Case-Control Studies | 3 | 2016 | 854 | 0.080 |
Why?
|
| Kidney Diseases | 1 | 2013 | 243 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 1 | 2012 | 131 | 0.080 |
Why?
|
| Nuclear Matrix | 1 | 1990 | 1 | 0.080 |
Why?
|
| Intermediate Filament Proteins | 1 | 1990 | 11 | 0.080 |
Why?
|
| Heat-Shock Proteins | 1 | 1990 | 38 | 0.080 |
Why?
|
| Reoviridae | 1 | 2009 | 2 | 0.080 |
Why?
|
| eIF-2 Kinase | 1 | 2009 | 6 | 0.080 |
Why?
|
| Subcellular Fractions | 1 | 2009 | 15 | 0.080 |
Why?
|
| Drosophila melanogaster | 1 | 1990 | 43 | 0.080 |
Why?
|
| Cytoskeleton | 2 | 1986 | 20 | 0.080 |
Why?
|
| Female | 5 | 2018 | 19942 | 0.070 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2008 | 1 | 0.070 |
Why?
|
| Chemokine CCL1 | 1 | 2008 | 1 | 0.070 |
Why?
|
| Chemokine CCL17 | 1 | 2008 | 1 | 0.070 |
Why?
|
| Palatine Tonsil | 1 | 2008 | 8 | 0.070 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2008 | 3 | 0.070 |
Why?
|
| Carrier State | 1 | 2008 | 22 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 246 | 0.070 |
Why?
|
| Cell Cycle Proteins | 1 | 2009 | 52 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2009 | 90 | 0.070 |
Why?
|
| Male | 5 | 2016 | 19437 | 0.070 |
Why?
|
| Dendritic Cells | 1 | 2008 | 61 | 0.070 |
Why?
|
| Adjuvants, Immunologic | 1 | 2008 | 61 | 0.070 |
Why?
|
| Gene Components | 1 | 2008 | 3 | 0.070 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2008 | 10 | 0.070 |
Why?
|
| Young Adult | 1 | 2015 | 2648 | 0.070 |
Why?
|
| Cell Death | 2 | 2017 | 79 | 0.070 |
Why?
|
| Models, Molecular | 2 | 2013 | 204 | 0.070 |
Why?
|
| Cytochalasins | 2 | 1986 | 2 | 0.060 |
Why?
|
| Phenotype | 3 | 2013 | 621 | 0.060 |
Why?
|
| North Carolina | 2 | 2016 | 1300 | 0.060 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 37 | 0.060 |
Why?
|
| Culture Media, Conditioned | 1 | 2007 | 50 | 0.060 |
Why?
|
| African Americans | 1 | 2013 | 1335 | 0.060 |
Why?
|
| Flow Cytometry | 1 | 2007 | 183 | 0.060 |
Why?
|
| Base Sequence | 4 | 2005 | 252 | 0.060 |
Why?
|
| Microscopy, Electron | 4 | 1991 | 43 | 0.060 |
Why?
|
| Genetic Vectors | 1 | 2006 | 108 | 0.060 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2005 | 15 | 0.060 |
Why?
|
| Radiation Tolerance | 1 | 2004 | 27 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2004 | 38 | 0.050 |
Why?
|
| Hybrid Cells | 1 | 2003 | 4 | 0.050 |
Why?
|
| Cytochalasin D | 3 | 2016 | 4 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 792 | 0.050 |
Why?
|
| Myosin Type II | 1 | 2022 | 1 | 0.050 |
Why?
|
| Fucose | 1 | 2022 | 2 | 0.050 |
Why?
|
| Adenosine Triphosphatases | 1 | 2022 | 14 | 0.050 |
Why?
|
| Virulence Factors | 1 | 2022 | 11 | 0.050 |
Why?
|
| Mucins | 1 | 2022 | 16 | 0.050 |
Why?
|
| Carbon | 1 | 2022 | 13 | 0.050 |
Why?
|
| Protein Transport | 1 | 2022 | 80 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2022 | 71 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2022 | 82 | 0.050 |
Why?
|
| Escherichia coli | 1 | 2022 | 88 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2002 | 19 | 0.050 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2016 | 102 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2002 | 74 | 0.040 |
Why?
|
| Intermediate Filaments | 2 | 1993 | 4 | 0.040 |
Why?
|
| Diffusion | 1 | 2020 | 17 | 0.040 |
Why?
|
| Vaccination | 1 | 2022 | 156 | 0.040 |
Why?
|
| Autocrine Communication | 1 | 2020 | 5 | 0.040 |
Why?
|
| Capsid Proteins | 1 | 2019 | 9 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2019 | 543 | 0.040 |
Why?
|
| Chemical Fractionation | 1 | 1999 | 2 | 0.040 |
Why?
|
| Biological Transport | 1 | 1999 | 75 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 150 | 0.040 |
Why?
|
| Swine | 1 | 2019 | 228 | 0.040 |
Why?
|
| Temperature | 1 | 1998 | 58 | 0.040 |
Why?
|
| Viral Structural Proteins | 2 | 2016 | 7 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2018 | 131 | 0.030 |
Why?
|
| Aged | 2 | 2016 | 10260 | 0.030 |
Why?
|
| Cell Survival | 1 | 2018 | 288 | 0.030 |
Why?
|
| Serotyping | 2 | 2008 | 17 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 3 | 1993 | 95 | 0.030 |
Why?
|
| Hemolysis | 1 | 2017 | 11 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2017 | 21 | 0.030 |
Why?
|
| Middle Aged | 2 | 2016 | 11848 | 0.030 |
Why?
|
| Cell Count | 1 | 1997 | 51 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2017 | 55 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2017 | 58 | 0.030 |
Why?
|
| Vero Cells | 1 | 1996 | 3 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1996 | 14 | 0.030 |
Why?
|
| 3T3 Cells | 1 | 1996 | 11 | 0.030 |
Why?
|
| CHO Cells | 1 | 1996 | 29 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 1997 | 164 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2008 | 839 | 0.030 |
Why?
|
| Cricetinae | 1 | 1996 | 51 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1996 | 17 | 0.030 |
Why?
|
| Demecolcine | 1 | 2016 | 1 | 0.030 |
Why?
|
| Nocodazole | 1 | 2016 | 1 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 1996 | 74 | 0.030 |
Why?
|
| Species Specificity | 1 | 1996 | 98 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 70 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2018 | 603 | 0.030 |
Why?
|
| Primates | 1 | 1996 | 128 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 264 | 0.030 |
Why?
|
| Brefeldin A | 1 | 2015 | 3 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2010 | 1233 | 0.030 |
Why?
|
| Viral Envelope Proteins | 1 | 2015 | 11 | 0.030 |
Why?
|
| Fluorescence | 1 | 2015 | 22 | 0.030 |
Why?
|
| Autoantigens | 1 | 2015 | 15 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2015 | 111 | 0.030 |
Why?
|
| Multiprotein Complexes | 2 | 2005 | 19 | 0.030 |
Why?
|
| Kinetics | 2 | 2004 | 250 | 0.030 |
Why?
|
| Adenovirus Early Proteins | 2 | 1991 | 2 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2015 | 243 | 0.030 |
Why?
|
| Virus Release | 1 | 2013 | 1 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2013 | 45 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2013 | 50 | 0.020 |
Why?
|
| Keratins | 1 | 1993 | 39 | 0.020 |
Why?
|
| Cystatin C | 1 | 2013 | 33 | 0.020 |
Why?
|
| Nonlinear Dynamics | 1 | 2013 | 77 | 0.020 |
Why?
|
| Endopeptidases | 1 | 1993 | 29 | 0.020 |
Why?
|
| HCT116 Cells | 1 | 2012 | 10 | 0.020 |
Why?
|
| Leupeptins | 1 | 2012 | 7 | 0.020 |
Why?
|
| Freeze Drying | 1 | 2012 | 3 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2018 | 637 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 79 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 287 | 0.020 |
Why?
|
| Tensile Strength | 1 | 2012 | 60 | 0.020 |
Why?
|
| Albuminuria | 1 | 2013 | 172 | 0.020 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2012 | 42 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2013 | 302 | 0.020 |
Why?
|
| Linear Models | 1 | 2013 | 425 | 0.020 |
Why?
|
| Rats | 1 | 1996 | 1895 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2012 | 203 | 0.020 |
Why?
|
| Interferon Type I | 1 | 2012 | 11 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2012 | 132 | 0.020 |
Why?
|
| RNA | 1 | 2012 | 94 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2012 | 285 | 0.020 |
Why?
|
| Antigens, Viral, Tumor | 1 | 1991 | 1 | 0.020 |
Why?
|
| Lysogeny | 1 | 1991 | 1 | 0.020 |
Why?
|
| Inclusion Bodies, Viral | 1 | 1991 | 4 | 0.020 |
Why?
|
| DNA | 1 | 2012 | 223 | 0.020 |
Why?
|
| Cell Transformation, Viral | 1 | 1991 | 9 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 2012 | 240 | 0.020 |
Why?
|
| Genome, Viral | 1 | 2010 | 12 | 0.020 |
Why?
|
| Prevalence | 1 | 2013 | 955 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1990 | 8 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2012 | 393 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 821 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1990 | 81 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 186 | 0.020 |
Why?
|
| Polyribosomes | 2 | 1986 | 2 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 1990 | 140 | 0.020 |
Why?
|
| Virus Activation | 1 | 2008 | 8 | 0.020 |
Why?
|
| Listeria monocytogenes | 1 | 2008 | 8 | 0.020 |
Why?
|
| Interleukin-23 | 1 | 2008 | 21 | 0.020 |
Why?
|
| Cell Communication | 1 | 2008 | 37 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2008 | 59 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2008 | 257 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2008 | 454 | 0.020 |
Why?
|
| Protein Phosphatase 2 | 1 | 2006 | 5 | 0.020 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2006 | 9 | 0.020 |
Why?
|
| Infant | 1 | 2010 | 1010 | 0.020 |
Why?
|
| RNA, Heterogeneous Nuclear | 1 | 1986 | 1 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2006 | 120 | 0.010 |
Why?
|
| Prognosis | 1 | 2010 | 1534 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 2005 | 3 | 0.010 |
Why?
|
| Risk Factors | 1 | 2013 | 3934 | 0.010 |
Why?
|
| Phylogeny | 1 | 2005 | 67 | 0.010 |
Why?
|
| Histone Chaperones | 1 | 2005 | 1 | 0.010 |
Why?
|
| Cullin Proteins | 1 | 2004 | 6 | 0.010 |
Why?
|
| Threonine | 1 | 2004 | 11 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 25 | 0.010 |
Why?
|
| Ubiquitin | 1 | 2004 | 15 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2004 | 39 | 0.010 |
Why?
|
| Radiation, Ionizing | 1 | 2004 | 21 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2004 | 7 | 0.010 |
Why?
|
| Receptors, Virus | 1 | 2004 | 12 | 0.010 |
Why?
|
| Integrins | 1 | 2004 | 17 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2004 | 78 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2005 | 146 | 0.010 |
Why?
|
| Protein Binding | 1 | 2004 | 244 | 0.010 |
Why?
|
| DNA Primers | 1 | 2004 | 84 | 0.010 |
Why?
|
| Edema | 1 | 2004 | 29 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2004 | 66 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2004 | 196 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2004 | 140 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2004 | 258 | 0.010 |
Why?
|
| Genotype | 1 | 2004 | 702 | 0.010 |
Why?
|
| Inflammation | 1 | 2004 | 506 | 0.010 |
Why?
|
| Kidney | 1 | 2004 | 521 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1993 | 34 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1992 | 7 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1992 | 20 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 42 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1992 | 245 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 4 | 0.010 |
Why?
|
| Time Factors | 1 | 1993 | 2204 | 0.000 |
Why?
|
| Cell Fractionation | 1 | 1986 | 8 | 0.000 |
Why?
|